Characterization of the interaction between the tumour suppressor p53 and heme and its role in the protein conformational dynamics studied by various spectroscopic techniques and hydrogen/deuterium exchange coupled with mass spectrometry.

Conformational dynamics Heme interaction Heme-responsive sensor Intrinsically disordered regions Signal transduction p53 transcription factor

Journal

Journal of inorganic biochemistry
ISSN: 1873-3344
Titre abrégé: J Inorg Biochem
Pays: United States
ID NLM: 7905788

Informations de publication

Date de publication:
06 2023
Historique:
received: 17 12 2022
revised: 04 03 2023
accepted: 06 03 2023
medline: 11 4 2023
pubmed: 20 3 2023
entrez: 19 3 2023
Statut: ppublish

Résumé

The tumour suppressor p53 regulates the expression of a myriad of proteins that are important for numerous cellular processes, including apoptosis, cell cycle arrest, DNA repair, metabolism, and even autophagy and ferroptosis. Aside from DNA, p53 can interact with many types of partners including proteins and small organic molecules. The ability of p53 to interact with heme has been reported so far. In this study, we used various spectroscopic studies to conduct a thorough biophysical characterization of the interaction between p53 and heme concerning the oxidation, spin, coordination, and ligand state of heme iron. We found that the p53 oligomeric state and zinc biding ability are preserved upon the interaction with heme. Moreover, we described the effect of heme binding on the conformational dynamics of p53 by hydrogen/deuterium exchange coupled with mass spectrometry. Specifically, the conformational flexibility of p53 is significantly increased upon interaction with heme, while its affinity to a specific DNA sequence is reduced by heme. The inhibitory effect of DNA binding by heme is partially reversible. We discuss the potential heme binding sites in p53 with respect to the observed conformational dynamics changes and perturbed DNA-binding ability of p53 upon interaction with heme.

Identifiants

pubmed: 36934467
pii: S0162-0134(23)00062-4
doi: 10.1016/j.jinorgbio.2023.112180
pii:
doi:

Substances chimiques

Hydrogen 7YNJ3PO35Z
Deuterium AR09D82C7G
Heme 42VZT0U6YR
Tumor Suppressor Protein p53 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112180

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jakub Vavra reports financial support was provided by Charles University. Dariya Savchenko reports financial support was provided by Ministry of Education Youth and Sports of the Czech Republic. Marketa Martinkova reports financial support was provided by Ministry of Education Youth and Sports of the Czech Republic. Petr Pompach reports financial support was provided by Ministry of Education Youth and Sports of the Czech Republic.

Auteurs

Jakub Vávra (J)

Department of Biochemistry, Faculty of Science, Charles University, Prague 2 128 43, Czech Republic; National Radiation Protection Institute, Prague 4, 140 00, Czech Republic.

Artur Sergunin (A)

Department of Biochemistry, Faculty of Science, Charles University, Prague 2 128 43, Czech Republic.

Petr Pompach (P)

Department of Biochemistry, Faculty of Science, Charles University, Prague 2 128 43, Czech Republic.

Dariya Savchenko (D)

Institute of Physics of the Czech Academy of Sciences, Prague 8, 182 21, Czech Republic.

Jakub Hraníček (J)

Department of Analytical Chemistry, Faculty of Science, Charles University, Prague 2 128 43, Czech Republic.

Ivana Šloufová (I)

Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague 2 128 43, Czech Republic.

Toru Shimizu (T)

Department of Biochemistry, Faculty of Science, Charles University, Prague 2 128 43, Czech Republic.

Markéta Martínková (M)

Department of Biochemistry, Faculty of Science, Charles University, Prague 2 128 43, Czech Republic. Electronic address: marketa.martinkova@natur.cuni.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH